Valve Replacement
Transcatheter Aortic Valve Implantation in the Hybrid Catheterisation
Laboratory – Navigating into the Future
Michael Lauterbach,1 Bruno Sontag1 and Karl Eugen Hauptmann2
1. Consultant Cardiologist; 2. Head of Department, Department of Medicine III, Krankenhaus der Barmherzigen
Brüder Trier, a teaching affiliate of the University Medical Center Mainz
Abstract
Transcatheter aortic valve implantation (TAVI) has emerged as a viable treatment option for high-risk patients with symptomatic, senile
degenerative aortic stenosis. Since the first TAVI in 2002, the technology has evolved tremendously. With the downsizing of the device
delivery catheter profile, vascular access site complications have decreased significantly. Current access routes are transfemoral,
subclavian, transapical and transaortic, with most centres preferring a `transfem Valve Replacement Transcatheter Aortic Valve I Valve Replacement the procedure and patien Transcatheter Aortic Valve Implantation in the Hy Valve Replacement Access Route As learned earl Transcatheter Aortic Valve Implantation in the Hy Valve Replacement Figure 2: HeartNavigator – L